Your session is about to expire
← Back to Search
Radiation Therapy
Single Pre-Operative Radiation Therapy for Breast Cancer (SPORT Trial)
Phase 1
Waitlist Available
Research Sponsored by Maisonneuve-Rosemont Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Summary
The purpose of this study is to determine if partial breast irradiation administered in a single preoperative fraction is tolerable.
Eligible Conditions
- Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute toxicity
Secondary outcome measures
Chronic toxicity
Cosmetic outcome
Other outcome measures
Ipsilateral breast cancer recurrence
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single Pre-Operative Radiation TherapyExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Single Pre-Operative Radiation Therapy
2012
Completed Phase 1
~10
Find a Location
Who is running the clinical trial?
Maisonneuve-Rosemont HospitalLead Sponsor
99 Previous Clinical Trials
36,313 Total Patients Enrolled
1 Trials studying Breast Cancer
80 Patients Enrolled for Breast Cancer
Michael Yassa, MDStudy ChairMaisonneuve-Rosemon Hospital
Share this study with friends
Copy Link
Messenger